>It may well be better for GTCB (the shining star of NPPS companies) to partner with a company like DuPont or Monsanto who are one step away from big pharma.<
Such companies as DuPont and Monsanto, who have only historical connections to the pharmaceutical business, would not be the best choices for GTC to partner with, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”